Accurately predicting binding affinity constant (KA) is highly required to determine the
binding energetics of the driving forces in drug–DNA interactions. Recently, PD153035 …

Carboplatin is a chemotherapeutic drug, used for the treatment of different types of cancers,
particularly solid tumors. Carboplatin, like other platinum containing drugs, exerts its …

Deoxyribonucleic acid (DNA) is a major target in research pertaining to antiviral and
anticancer therapies since it is the principal genetic material that controls vital biological …

Abstract Structure-based drug designing has become a significant subject of research, and
several clinically promising DNA binding compounds were evolved using this technique …

In the present study, we have explored the mode of binding of an anti-leukemic drug,
imatinib (IMT) mesylate with DNA and resulting conformational changes in DNA double …

The binding interaction of niraparib (MK-4827), a poly (ADP-ribose) polymerase inhibitor,
with calf thymus deoxyribonucleic acid (ctDNA) has been explored by various theoretical …

Diplacone was a C-geranylated flavanone derivative with great antioxidation and anti-
inflammatory activity. Its structure could be identified as eriodictyol with a C 10 side chain …

In the present work, the binding interaction between lenalidomide (LEN) and calf thymus
DNA (ct-DNA) was systematically studied by using fluorescence, ultraviolet–visible (UV–vis) …

The over‐use of antibiotics has caused a number of problems such as contamination of
antibiotic residues and virus resistance, and therefore has attracted global attention. In this …

The interaction of calf thymus DNA with nevirapine at physiological pH was studied by using
absorption, circular dichroism, viscosity, differential pulse voltammetry, fluorescence …